Goldhaber, S Z <br/><br/>
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.  [electronic resource] 

 -  Journal of the American College of Cardiology  Jul 1992 
 - 24-30 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0735-1097 
<br/><br/><label>Standard No.: </label>10.1016/0735-1097(92)90132-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Cause of Death<br/>Confidence Intervals<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Pulmonary Embolism--blood<br/>Radiography<br/>Recombinant Proteins--therapeutic use<br/>Thrombolytic Therapy--adverse effects<br/>Tissue Plasminogen Activator--therapeutic use<br/>Urokinase-Type Plasminogen Activator--therapeutic use